InvestorsHub Logo
Followers 48
Posts 203
Boards Moderated 0
Alias Born 10/17/2018

Re: None

Monday, 06/15/2020 8:17:56 PM

Monday, June 15, 2020 8:17:56 PM

Post# of 424560
For anyone interested in a more complete understanding of the issues at hand in Amarin’s appeal case, and of how the appellate panel will be thinking about this case, I strongly recommend that you read the Cyclobenzaprine decision in its entirety. Cyclobenzaprine was Singer’s case, with uncanny overlaps with Amarin’s current appeal, and the decision explains in clear language how the relevant precedents will be applied by the court. As you read the decision, it’s quite clear where and how you can substitute the facts of Cyclobenzaprine with the very similar facts of Amarin v. generics.


https://caselaw.findlaw.com/us-federal-circuit/1608878.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News